Biognos

Biognos is a privately held Swedish computational drug discovery company focused on ligand-based and structure-based virtual screening. The company provides molecular modelling and virtual screening services to pharmaceutical and biotech companies that lack sufficient in-house modelling capabilities, and it also supports academic groups in chemical biology. In addition to fee-for-service work, Biognos has described selected in-house research efforts conducted in collaboration with university groups. The business appears to be centered on discovery-stage enablement rather than a disclosed clinical-stage therapeutic pipeline.